BPA Call 75F40124A00002-75F40124F19002

Award Date 7/16/24
Potential Completion Date 2/7/25
Potential Value $253K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Washington, DC 20005, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a Blanket Purchase Agreement (BPA) call with Versar, Inc., a global project management company, to provide consulting and peer review services related to food contaminants for the U.S. Food and Drug Administration (FDA). The contract has a ceiling value of $1,315,464.07 and a completion date of October 30, 2025. The contract is a firm fixed-price type awarded under the Multiple Award Schedule (MAS) program. The contract does not have a set-aside designation....
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Versar, Inc., a global project management company, for "Consultation and Peer Review: Risk Assessment for Contaminants in Food (Maternal and Infant Health)." The BPA call, which is not set aside, has a potential value of $243,704.08 and a completion date of November 9, 2023. Versar, Inc. will provide professional services and peer review support...
This is a $76,236.49 firm fixed-price Blanket Purchase Agreement (BPA) Call contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Versar, Inc., a for-profit organization. The contract provides "SCIENTIFIC AND ANALYTIC CONSULTATIVE SERVICE FOR RISK ASSESSMENTS" and is under the General Services Administration's Professional Services Schedule (PSS) contract vehicle. The award has no set-aside designation, and the ultimate completion date is March 30, 2021....
This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Versar, Inc., a global project management company. The $83,266.40 firm fixed-price contract is a BPA (Blanket Purchase Agreement) call under a larger $12.5 million BPA established by the FDA for peer review and scientific assessment support related to tobacco products. The contract is for consultative services and external peer...
The Department of Health and Human Services Food and Drug Administration awarded Versar, Inc. a firm fixed price Blanket Purchase Agreement (BPA) call contract with a potential value of $109,521.00. The contract is for "Consultation and External Peer Review for Risk and Safety Assessments" under the existing BPA #HHSF223201700015B, which is part of the General Services Administration's Professional Services Schedule. Versar is a global project management firm that specializes in...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $1,858,710.48 delivery order contract to Versar Inc. under the Multiple Award Schedule (MAS) contract vehicle. The contract calls for Versar to provide consultative services and external peer review for scientific assessments, literature reviews, and models for the Division of Risk and Decision Analysis within HHS FDA. Performance will take place in Washington, D.C. from September 1, 2023 through March...
This is a Firm Fixed Price call under a Blanket Purchase Agreement (BPA) awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Versar, Inc., a global project management company. The contract, valued at $108,804.61, is for external peer review services related to scientific support documents for potential tobacco product standards. The BPA falls under the General Services Administration's Professional Services Schedule (PSS) contract vehicle, which Versar...
This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Versar, Inc., a global project management company. The $84,083.69 Blanket Purchase Agreement (BPA) call was placed under the General Services Administration's (GSA) Professional Services Schedule (PSS), a government-wide acquisition contract vehicle. The contract is for peer review and scientific assessment support related to...
This BPA call contract was awarded by the Department of Health and Human Services Food and Drug Administration to Versar, Inc., a global project management company that provides sustainable solutions to government and commercial clients. The contract, valued at $119,398.26, is for scientific and analytic consultative services for risk assessments. The contract is a firm fixed price BPA call under the General Services Administration's Professional Services Schedule (PSS). Versar has received...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Versa Integrated Solutions Inc. (Versa), an SBA-certified 8(a) program participant and minority-owned small disadvantaged business. The contract is for $99,442.24 and involves an audiovisual systems upgrade. Versa is a prime contractor experienced in providing IT services, human capital planning, facilities support, and audiovisual integration services to various...

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded to Versar, Inc. by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services. The $252,756.37 contract is for peer review and expert elicitation services, with a period of performance through February 7, 2025. Versar is a global project management and professional services firm that has previously supported the FDA, Environmental Protection Agency, and other federal agencies with various technical and scientific assessments. This award is under the Multiple Award Schedule (MAS) contract vehicle, allowing the FDA to efficiently procure Versar's specialized expertise as needed. The contract does not have a set-aside designation.

Generated 12/13/24, 9:41 AM